Literature DB >> 20851886

Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains.

Sonia Kapur1, Mehran Amoui, Chandrasekhar Kesavan, Xiaoguang Wang, Subburaman Mohan, David J Baylink, K-H William Lau.   

Abstract

This study investigated the role of leptin receptor (Lepr) signaling in determining the bone mechanosensitivity and also evaluated whether differences in the Lepr signaling may contribute to the differential osteogenic response of the C57BL/6J (B6) and C3H/HeJ (C3H) pair of mouse strains to mechanical stimuli. This study shows that a loading strain of ∼2,500 με, which was insufficient to produce a bone formation response in B6 mice, significantly increased bone formation parameters in leptin-deficient ob(-)/ob(-) mice and that a loading strain of ∼3,000 με also yielded greater osteogenic responses in Lepr-deficient db(-)/db(-) mice than in wild-type littermates. In vitro, a 30-min steady shear stress increased [(3)H]thymidine incorporation and Erk1/2 phosphorylation in ob(-)/ob(-) osteoblasts and db(-)/db(-) osteoblasts much greater than those in corresponding wild-type osteoblasts. The siRNA-mediated suppression of Lepr expression in B6 osteoblasts enhanced (but in osteoblasts of C3H (the mouse strain with poor bone mechanosensitivity) restored) their anabolic responses to shear stress. The Lepr signaling (leptin-induced Jak2/Stat3 phosphorylation) in C3H osteoblasts was higher than that in B6 osteoblasts. One of the three single nucleotide polymorphisms in the C3H Lepr coding region yielded an I359V substitution near the leptin binding region, suggesting that genetic variation of Lepr may contribute to a dysfunctional Lepr signaling in C3H osteoblasts. In conclusion, Lepr signaling is a negative modulator of bone mechanosensitivity. Genetic variations in Lepr, which result in a dysfunctional Lepr signaling in C3H mice, may contribute to the poor osteogenic response to loading in C3H mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851886      PMCID: PMC2988366          DOI: 10.1074/jbc.M110.169714

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice.

Authors:  Y Kodama; Y Umemura; S Nagasawa; W G Beamer; L R Donahue; C R Rosen; D J Baylink; J R Farley
Journal:  Calcif Tissue Int       Date:  2000-04       Impact factor: 4.333

2.  Mechanosensitivity of the rat skeleton decreases after a long period of loading, but is improved with time off.

Authors:  L K Saxon; A G Robling; I Alam; C H Turner
Journal:  Bone       Date:  2005-03       Impact factor: 4.398

3.  Bone response to in vivo mechanical loading in C3H/HeJ mice.

Authors:  E A Pedersen; M P Akhter; D M Cullen; D B Kimmel; R R Recker
Journal:  Calcif Tissue Int       Date:  1999-07       Impact factor: 4.333

4.  Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.

Authors:  Apurva K Srivastava; Sanjay Kapur; Suburaman Mohan; Hongrun Yu; Sonia Kapur; Jon Wergedal; David J Baylink
Journal:  J Bone Miner Res       Date:  2004-12-27       Impact factor: 6.741

5.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

6.  Mechanical loading-induced gene expression and BMD changes are different in two inbred mouse strains.

Authors:  Chandrasekhar Kesavan; Subburaman Mohan; Susanna Oberholtzer; Jon E Wergedal; David J Baylink
Journal:  J Appl Physiol (1985)       Date:  2005-07-14

7.  Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin.

Authors:  Michi Hirosawa; Mutsuko Minata; Kouji H Harada; Toshiaki Hitomi; Andree Krust; Akio Koizumi
Journal:  Biochem Biophys Res Commun       Date:  2008-04-24       Impact factor: 3.575

8.  Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.

Authors:  Leonora Niv-Spector; Dana Gonen-Berger; Isabelle Gourdou; Eva Biener; Eugene E Gussakovsky; Yackir Benomar; Krishnan V Ramanujan; Mohammed Taouis; Brian Herman; Isabelle Callebaut; Jean Djiane; Arieh Gertler
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

9.  PTP-1B is an essential positive regulator of platelet integrin signaling.

Authors:  Elena Garcia Arias-Salgado; Fawaz Haj; Christophe Dubois; Barry Moran; Ana Kasirer-Friede; Barbara C Furie; Bruce Furie; Benjamin G Neel; Sanford J Shattil
Journal:  J Cell Biol       Date:  2005-08-22       Impact factor: 10.539

10.  Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.

Authors:  I K Lund; J A Hansen; H S Andersen; N P H Møller; N Billestrup
Journal:  J Mol Endocrinol       Date:  2005-04       Impact factor: 5.098

View more
  20 in total

1.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

Review 2.  Influence of body weight on bone mass, architecture and turnover.

Authors:  Urszula T Iwaniec; Russell T Turner
Journal:  J Endocrinol       Date:  2016-06-27       Impact factor: 4.286

Review 3.  Role of Marrow Adipocytes in Regulation of Energy Metabolism and Bone Homeostasis.

Authors:  Jillian Cornish; Tao Wang; Jian-Ming Lin
Journal:  Curr Osteoporos Rep       Date:  2018-04       Impact factor: 5.096

4.  Uterine artery leptin receptors during the ovarian cycle and pregnancy regulate angiogenesis in ovine uterine artery endothelial cells†.

Authors:  Vladimir E Vargas; Rosalina Villalon Landeros; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

5.  Paradoxical effects of partial leptin deficiency on bone in growing female mice.

Authors:  Kenneth A Philbrick; Russell T Turner; Adam J Branscum; Carmen P Wong; Urszula T Iwaniec
Journal:  Anat Rec (Hoboken)       Date:  2015-10-07       Impact factor: 2.064

6.  Fak-Mapk, Hippo and Wnt signalling pathway expression and regulation in distraction osteogenesis.

Authors:  Jian Song; Bin Ye; Hanghang Liu; Ruiye Bi; Nian Zhang; Jing Hu; En Luo
Journal:  Cell Prolif       Date:  2018-03-05       Impact factor: 6.831

7.  Strain differences in the attenuation of bone accrual in a young growing mouse model of insulin resistance.

Authors:  Elizabeth Rendina-Ruedy; Jennifer L Graef; McKale R Davis; Kelsey D Hembree; Jeffrey M Gimble; Stephen L Clarke; Edralin A Lucas; Brenda J Smith
Journal:  J Bone Miner Metab       Date:  2015-06-10       Impact factor: 2.626

8.  Role of osteoglycin in the linkage between muscle and bone.

Authors:  Ken-ichiro Tanaka; Erika Matsumoto; Yoshiko Higashimaki; Takenobu Katagiri; Toshitsugu Sugimoto; Susumu Seino; Hiroshi Kaji
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

Review 9.  Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading.

Authors:  Joanna S Price; Toshihiro Sugiyama; Gabriel L Galea; Lee B Meakin; Andrew Sunters; Lance E Lanyon
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

10.  Peripheral leptin regulates bone formation.

Authors:  Russell T Turner; Satya P Kalra; Carmen P Wong; Kenneth A Philbrick; Laurence B Lindenmaier; Stephane Boghossian; Urszula T Iwaniec
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.